u/insulin_syringe_ian

if it matters, ask somebody qualified in your own jurisdiction

Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.

Correction: that is the claimed figure, and the measured one is the higher of the two in your own screenshot.

Purity methods differ by compound class. A gradient and wavelength developed for one peptide will not necessarily resolve the relevant impurities of another.

constipation for the first eight days after each step, then nothing, every single time. Predictable enough that I started planning my week around it.

The effect on gastric emptying is most pronounced early and attenuates with continued dosing, which is the mechanism behind the "it settles at a stable dose" pattern the whole board reports.

WXT BPC, batch matched the paperwork, Janoshik came back 98.7% against a claimed 98.0%. Paid for it myself, posting it because the log is only worth anything if people do.

Careful with the trend claim. Four results over two years is a very sparse series to draw a line through.

two labs, two gradients, two honest answers

Agreed. Slowing down at meals did more for my nausea than everything I bought to fix it, which was embarrassing to discover.

Why regional stock keeps coming up in every thread on this board.

If the line you want is held in a warehouse in your own country, your order is a domestic shipment. There is no import event, no clearance stage and no notice to manage. That is not a workaround; it is a different transaction.

So the useful pre-order question is which lines a supplier actually holds regionally rather than drop-ships from origin. It is one email, the answer is usually a list, and for anybody who has spent a fortnight watching a tracking page it reframes the whole problem.

annotate the weeks where something else changed

The four columns that survive, after several people here have tried and abandoned much more elaborate systems.

Date. Dose. One number measured under consistent conditions. A short note when anything unusual happened. That is it. Anything more and you will stop, and a log you stop keeping is worth less than a crude one you maintain.

Add a waist measurement monthly if you can be bothered, and a sleep column if you want the one variable that explains the most confusing weeks. Everything else can be reconstructed from those, and nothing can be reconstructed from a log you abandoned in week nine.

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

Kept one line a week for 11 months. It was pointless for the first eight weeks and then it was the most useful document I owned.

This. The trend across separate lots is the number that tells you about a process rather than a vial.

Are you eating in the couple of hours before you sleep?

Yes. Retention time is a hypothesis about identity. Mass is the answer.

For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.

Yes — the day-two-to-day-four window is so consistent across this board that it is almost diagnostic.

Why two honest labs report different numbers on the same vial.

Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.

Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.

A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

This. A shoulder that does not baseline-resolve is a question, not a quantity.

I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.

three lots beats three tests on one lot

This is why the template has a batch field. Without it the result is about a vial nobody can identify.

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

Did you run a blank between injections?

That symptom is not the one being described upthread. Two different things with similar names and the answers are not interchangeable.